Multiple Sclerosis Clinical Trial
Health Promotion and Wellness Program for Adults With Disabling Conditions
Summary
The objective of this study is to conduct a randomized controlled pilot study to examine the efficacy, feasibility and safety of the SystemCHANGEâ„¢(SC) health promotion and wellness program in adults with disabling conditions. Particularly, the study will focus on developing a program of research on adapting and testing SC weight management interventions in overweight and obese stroke survivors and persons with chronic inflammatory autoimmune/immune-mediated diseases, specifically those with multiple sclerosis (MS) and rheumatoid arthritis (RA).
Full Description
Individuals with disabling conditions, such as stroke, multiple sclerosis, or rheumatoid arthritis, face many barriers to engaging in physical activity, healthy nutritional habits, and good sleep hygiene. This leads to weight gain, de-conditioning, and declines in upper- and lower- extremity function, which makes it even more difficult to engage in healthy behaviors, thereby perpetuating a cycle of functional decline. Developing an effective weight management intervention may be a strategy for disrupting this disabling cycle and reducing the impact of the disease. Fostering a positive social environment may help adults with disabling conditions overcome barriers to engaging in healthy behaviors. SystemCHANGE (SC) is a new behavior change program that uses approaches consistent with social ecological theories and process improvement techniques (i.e. changing the dynamics of a system or group) to increase social support in lifestyle behaviors that promote energy balance. SC focuses on redesigning the social environment using a series of trial-and-error "experiments", which is in contrast to cognitive-behavioral interventions that focus on changing a person's viewpoint of a situation and increasing motivation. In a SC intervention, individuals are taught a set of skills to assist them in incorporating habitual lifestyle behaviors into their daily systems so they succeed despite wavering motivation. The rationale for developing a weight management intervention for these patients is to slow disability progression and prevent secondary conditions.
Eligibility Criteria
Inclusion Criteria Stroke:
Physician-confirmed diagnosis of stroke (> 6 weeks)
Body mass index between 23 to 45 kg/m2
Age 30 to 75 years
Exclusion Criteria Stroke:
Pregnant or plans to become pregnant in the next 6 months
Current participation in a face-to-face weight management program
Uncontrolled diabetes (hospitalization within the prior 6 months)
Serious mental illness
Thyroid and adrenal gland diseases
Inability to walk 3 meters with or without a cane or walker
Severe cardiopulmonary disease that limits engagement in physical activity (e.g., myocardial infarction, congestive heart failure, coronary artery bypass grafting or valve replacement during the past three months, serious cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, and pulmonary embolus) or abnormal blood pressure or heart rate response after the 6-Minute Walking Test (e.g., a drop in systolic blood pressure of >10mmHg from baseline)
Severe cognitive deficits (Screening questioanire called the Short Orientation Memory-Concentration < 12)
Currently taking oral corticosteroids, antipsychotic (except for depression medication), or medications specifically for weight loss
3 or more falls in the past month
Bulimia
Unable to speak English over the phone
Able to eat independently and is not on a special diet because of difficulty in swallowing
Unstable weight (gained or lost >10lbs in the last two months)
Inclusion Criteria MS or RA:
Physician-confirmed diagnosis of multiple sclerosis or rheumatoid arthritis
Body mass index between 23 to 45 kg/m2
Exclusion Criteria MS or RA:
Pregnant or plans to become pregnant in the next 6 months
Current participation in a face-to-face weight management program
Uncontrolled diabetes (hospitalization within the prior 6 months)
Serious mental illness
Inability to walk 3 meters with or without a cane or walker
Severe cardiopulmonary disease that limits engagement in physical activity
Severe cognitive deficits (Short Orientation Memory-Concentration < 12)
Currently taking oral corticosteroids, antipsychotic (except for depression medication), or medications specifically for weight loss
3 or more falls in the past month
Bulimia
Unable to speak English
Uncontrolled thyroid or adrenal disease (change in type and dosage of medication within the prior 3 months)
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Cleveland Ohio, 44106, United States
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.